Начало・Списък с акции・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Отворен

СекторЗдравеопазване

95.59 -0.94

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

94.16

Максимум

96.98

Ключови измерители
By Trading Economics
Приходи	99M 239M
Продажби	-157M 2.1B
P/E Средно за сектора	23.852 64.641
EPS	2.09
Дивидентна доходност	1.05
Марж на печалбата	11.43
Служители	17,000
EBITDA	84M 538M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+2.66% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	1.05% 2.31%
Следващи печалби	5.08.2026 г.
Следваща дата на дивидент	30.10.2026 г.
Следваща дата на екс-дивидент	29.09.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-110M 18B
Предишно отваряне	96.53
Предишно затваряне	95.59

Настроения в новините

By Acuity

31%

69%

97 / 340 Класиране в Healthcare

Zimmer Biomet Holdings Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 23:11 ч. UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31.07.2026 г., 20:06 ч. UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30.07.2026 г., 19:03 ч. UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29.07.2026 г., 17:46 ч. UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28.07.2026 г., 20:03 ч. UTC

News

Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27.07.2026 г., 18:46 ч. UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24.07.2026 г., 19:06 ч. UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23.07.2026 г., 21:02 ч. UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22.07.2026 г., 18:36 ч. UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20.07.2026 г., 18:16 ч. UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Сравнение с други в отрасъла

Ценова промяна

Zimmer Biomet Holdings Inc Прогноза

Ценова цел

By TipRanks

2.66% нагоре

12-месечна прогноза

Среден 99.56 USD 2.66%

Висок 115 USD

Нисък 83 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Zimmer Biomet Holdings Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на Zimmer Biomet Holdings Inc през последните 3 месеца.

Настроение

By Acuity

97 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.